Angiogenesis in Gliomas

作者: Mujeeburahim Cheerathodi , Joseph H. McCarty

DOI: 10.1007/978-3-7091-1431-5_7

关键词:

摘要: Malignant brain tumors, including glioblastoma (GBM), display growth, survival, and invasive properties that are coupled to blood vessels vascular-derived factors. For example, GBM stem cells (GSCs) home perivascular niches tumor commonly disperse through the microenvironment via extracellular matrix (ECM)-rich vascular basement membranes. Anti-vascular agents target angiogenesis, particularly those involving endothelial cell growth factor-A (VEGF-A) its receptors, improve progression-free survival in patients. However, these benefits often transient due compensation by alternative angiogenic pathways. The detailed molecular mechanisms couple during progression as well following anti-angiogenesis therapies just beginning be elucidated, with various cytokines, factors, ECM proteins playing important roles. In this review we will highlight pathways link cerebral progression, invasion. We also discuss underlying GBM-induced a particular focus placed on roles for integrin adhesion receptors their protein ligands. Therapies angiogenesis other cancers summarized.

参考文章(280)
Solmaz Sahebjam, Evgenia Garoufalis, Marie-Christine Guiot, Thierry Muanza, Rolando Del Maestro, Kevin Petrecca, Rajesh Sharma, Petr Kavan, Bevacizumab use for recurrent high-grade glioma at McGill University Hospital. Canadian Journal of Neurological Sciences. ,vol. 40, pp. 241- 246 ,(2013) , 10.1017/S0317167100013809
R. M. Bachoo, R. S. Kim, K. L. Ligon, E. A. Maher, C. Brennan, N. Billings, S. Chan, C. Li, D. H. Rowitch, W. H. Wong, R. A. DePinho, Molecular diversity of astrocytes with implications for neurological disorders Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 8384- 8389 ,(2004) , 10.1073/PNAS.0402140101
David A Reardon, Gamal Akabani, R Edward Coleman, Allan H Friedman, Henry S Friedman, James E Herndon, Ilkcan Cokgor, Roger E McLendon, Charles N Pegram, James M Provenzale, Jennifer A Quinn, Jeremy N Rich, Lorna V Regalado, John H Sampson, Timothy D Shafman, Carol J Wikstrand, Terence Z Wong, Xiao-Guang Zhao, Michael R Zalutsky, Darell D Bigner, Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas Journal of Clinical Oncology. ,vol. 20, pp. 1389- 1397 ,(2002) , 10.1200/JCO.20.5.1389
Joseph H McCarty, Cell adhesion and signaling networks in brain neurovascular units Current Opinion in Hematology. ,vol. 16, pp. 209- 214 ,(2009) , 10.1097/MOH.0B013E32832A07EB
Candece L. Gladson, Joon H. Uhm, Athanassios P. Kyritsis, Nora P. Dooley, Jasti S. Rao, Jasti S. Rao, Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clinical Cancer Research. ,vol. 5, pp. 1587- 1594 ,(1999)
Fausto J. Rodriguez, Brent A. Orr, Keith L. Ligon, Charles G. Eberhart, Neoplastic Cells are a Rare Component in Human Glioblastoma Microvasculature Oncotarget. ,vol. 3, pp. 98- 106 ,(2012) , 10.18632/ONCOTARGET.427
R. L. C. Carvalho, F. Itoh, M.-J. Goumans, F. Lebrin, M. Kato, S. Takahashi, M. Ema, S. Itoh, M. van Rooijen, P. Bertolino, P. ten Dijke, C. L. Mummery, Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice Journal of Cell Science. ,vol. 120, pp. 4269- 4277 ,(2007) , 10.1242/JCS.013169
Marnix Jansen, Philip C de Witt Hamer, Antonella N Witmer, Dirk Troost, Cornelis J.F van Noorden, Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Research Reviews. ,vol. 45, pp. 143- 163 ,(2004) , 10.1016/J.BRAINRESREV.2004.03.001
M. Beatriz S. Lopes, Angiogenesis in brain tumors. Microscopy Research and Technique. ,vol. 60, pp. 225- 230 ,(2003) , 10.1002/JEMT.10260
Peter Carmeliet, Angiogenesis in life, disease and medicine Nature. ,vol. 438, pp. 932- 936 ,(2005) , 10.1038/NATURE04478